Firststic N Introducer
Contact Argon Medical Devices, Inc. ↗ Compare similar devices
FDA Clearance Information
The firststic n introducer was cleared by the FDA through the 510(k) pathway on December 19, 2014. It is manufactured by Argon Medical Devices and classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Used to facilitate the introduction and delivery of embolization coils during embolization procedures.
- Intended for use in the vasculature when controlled placement of embolization coils is required.
Clinical Applications
- Delivery of embolization coils to target blood vessels.
- Catheter-based embolization for management of abnormal or unwanted blood flow.
- Embolization procedures requiring controlled coil placement under fluoroscopic imaging.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The introducer must be used with compatible embolization coils and delivery components; exact compatibility depends on the device model and size.
- Use is performed under fluoroscopic or other appropriate image guidance by trained clinicians.
- The access site, catheter pathway, and target vessel determine the appropriate size and configuration; consult the current manufacturer instructions for use.
- MRI safety status should be confirmed from the current product labeling. Do not assume MRI compatibility based only on the device name.
- Potential risks are related to vascular access, catheterization, and embolization, including bleeding, infection, vessel injury, non-target embolization, ischemia, and device malfunction.
Procedures that use this device
Frequently Asked Questions
What are the clinical indications for firststic n introducer?
The firststic n introducer is indicated for use in embolization procedures, particularly for the delivery of embolization coils in vascular interventions.
What outcomes have been reported in clinical studies?
Studies have reported the device's effectiveness in facilitating embolization and achieving optimal implant-cement interfaces.
What complications have been reported?
Reported complications include challenges in achieving a conforming implant-cement interface, though specific adverse events were not detailed.